In 2017, the total prevalent cases of Retinal Vein Occlusion in 7MM was 2,225,011. The total prevalent cases of Retinal Vein Occlusion in the United States was 1,124,718 in 2017.
The market size of Retinal Vein Occlusion in the 7MM was USD 2,127.70 Million in 2017.
The key players in the Retinal Vein Occlusion Market include Novartis Pharmaceuticals, Taiwan Liposome Company, Aerie Pharmaceuticals, Graybug Vision, Outlook Therapeutics and The Emmes Company.
For more detailed information on Retinal Vein Occlusion Market, visit:
https://www.delveinsight.com/report-store/retinal-vein-occlusion-market